Quest Enlists Paige’s AI Expertise To Develop Software For Digitized Cancer Diagnosis
Executive Summary
Quest signed an agreement with Paige to develop regulatory-approved software and services to be marketed to expand digital pathology network for pathologists.
You may also be interested in...
Upgraded Paige Suite Gains CE-IVD and UKCA Marks
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
Another Set Of Eyes: US FDA Authorizes AI Software To Spot Prostate Cancer
The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.
HLTH 2022 Roundup: CEOs Of BD And Google Cloud On Innovation, Interoperability, AI
In this second roundup of HLTH, which drew more than 9,000 attendees to Las Vegas from 13-16 November, Medtech Insight highlights presentations from the CEOs of BD and Google Cloud and insights from an interview with BD’s CEO Tom Polen.